Compare Moderna, Inc. (MRNA) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Southern Copper Corp — how do they compare? Moderna, Inc. trades at $213.8 (market cap $78.65B), while Southern Copper Corp trades at $206.84 (market cap $167.74B). The key difference: Southern Copper Corp is far larger — about 2.1× Moderna, Inc.'s market cap, and Southern Copper Corp pays a 2.21% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Southern Copper Corp for 61 Days on average.
| MRNA | SCCO | |
|---|---|---|
Market Cap | $78.65B | $167.74B |
Volume | 37,373,437 | 853,110 |
Sector | Health | Basic Materials |
52-Week High | $203.46 | $219.70 |
52-Week Low | $22.36 | $120.02 |
Typical Hold Time | 59 Days | 61 Days |
Enterprise Value | $74.80B | $169.03B |
Dividend Yield | — | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $196.48, up 4.81% with strong technical momentum as it joins the Nasdaq-100 index. Despite recent earnings beats, the company faces fundamental challenges with revenue declining from $18.9B in 2022 to $1.92B in 2025 and negative net income margins exceeding -140%. The stock's 500% rally in 2026 has pushed valuations to elevated levels with P/S ratio of 35.08, creating divergence between technical strength and financial fundamentals.
While Nasdaq inclusion and cancer vaccine pipeline progress offer catalysts, Moderna faces significant execution risks amid declining COVID revenue and high valuation multiples. Analyst consensus remains cautious with only 28% buy ratings and $115.70 price target well below current levels, suggesting limited near-term upside despite technical bullish signals.
Southern Copper (SCCO) trades at $200.57, down 1.81% on the day, with technical indicators showing a neutral bias. The company demonstrates strong fundamentals with revenue growth from $13.42B in 2025 to projected $15.8B in 2026 and net income margins expanding to 35.87%. Recent earnings have consistently beaten expectations, and the company maintains robust profitability metrics including 50.07% ROE. A stock split and dividend payment are scheduled for August 2026.
SCCO presents a mixed investment case with strong operational performance offset by premium valuations. The stock trades above analyst consensus target of $167.67, suggesting limited near-term upside. Key risks include copper price volatility and competitive pressures, while growth catalysts include Mexican project pipeline development. Analyst sentiment remains divided with only 10.34% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
